A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy
Public ClinicalTrials.gov record NCT00785512. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Double-Blind, Placebo Controlled Study of the Long-Term Efficacy of Nebivolol in Hypertensive Patients After Withdrawal of Therapy
Study identification
- NCT ID
- NCT00785512
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Forest Laboratories
- Industry
- Enrollment
- 207 participants
Conditions and interventions
Conditions
Interventions
- Nebivolol Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 79 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2008
- Primary completion
- Jul 31, 2009
- Completion
- Not listed
- Last update posted
- Sep 14, 2010
Started 2008
United States locations
- U.S. sites
- 26
- U.S. states
- 10
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site | Chandler | Arizona | 85225 | — |
| Forest Investigative Site | Phoenix | Arizona | 85050 | — |
| Forest Investigative Site | Los Angeles | California | 90057 | — |
| Forest Investigative Site | Bradenton | Florida | 34203 | — |
| Forest Investigative Site | Brooksville | Florida | 34613 | — |
| Forest Investigative Site | DeLand | Florida | 32720 | — |
| Forest Investigative Site | Hollywood | Florida | 33021 | — |
| Forest Investigative Site | Miami | Florida | 33014 | — |
| Forest Investigative Site | Miami | Florida | 33156 | — |
| Forest Investigative Site | Miami | Florida | 33169 | — |
| Forest Investigative Site | Pembroke Pines | Florida | 33024 | — |
| Forest Investigative Site | St. Petersburg | Florida | 33709 | — |
| Forest Investigative Site | Auburn | Maine | 04210 | — |
| Forest Investigative Site | Cary | North Carolina | 27518 | — |
| Forest Investigative Site | Hickory | North Carolina | 28601 | — |
| Forest Investigative Site | Salisbury | North Carolina | 28144 | — |
| Forest Investigative Site | Wilmington | North Carolina | 28401 | — |
| Forest Investigative Site | Winston-Salem | North Carolina | 27103 | — |
| Forest Investigative Site | Cincinnati | Ohio | 45242 | — |
| Forest Investigative Site | Marion | Ohio | 43302 | — |
| Forest Investigative Site | Lancaster | Pennsylvania | 17601 | — |
| Forest Investigative Site | Mt. Pleasant | South Carolina | 29464 | — |
| Forest Investigative Site | Simpsonville | South Carolina | 29681 | — |
| Forest Investigative Site | New Tazewell | Tennessee | 37825 | — |
| Forest Investigative Site | Dallas | Texas | 75231 | — |
| Forest Investigative Site | Dallas | Texas | 75234 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00785512, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2010 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00785512 live on ClinicalTrials.gov.